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Abstract
Cyanobacteria are common inhabitants of freshwater lakes and reservoirs throughout the world. Under favourable
conditions, certain cyanobacteria can dominate the phytoplankton within a waterbody and form nuisance blooms. Case
reports and anecdotal references dating from 1949 describe a range of illnesses associated with recreational exposure
to cyanobacteria: hay fever-like symptoms, pruritic skin rashes and gastro-intestinal symptoms are most frequently
reported. Some papers give convincing descriptions of allergic reactions while others describe more serious acute
illnesses, with symptoms such as severe headache, pneumonia, fever, myalgia, vertigo and blistering in the mouth. A
coroner in the United States found that a teenage boy died as a result of accidentally ingesting a neurotoxic cyanotoxin
from a golf course pond. This death is the first recorded human fatality attributed to recreational exposure to
cyanobacteria, although uncertainties surround the forensic identification of the suspected cyanotoxin in this case.
We systematically reviewed the literature on recreational exposure to freshwater cyanobacteria. Epidemiological data
are limited, with six studies conducted since 1990. Statistically significant increases in symptoms were reported in
individuals exposed to cyanobacteria compared to unexposed counterparts in two Australian cohort studies, though
minor morbidity appeared to be the main finding. The four other small studies (three from the UK, one Australian) did
not report any significant association. However, the potential for serious inj u r y  o r  d e a t h  r e m a i n s ,  a s  f r e s h w a t e r
cyanobacteria under bloom conditions are capable of producing potent toxins that cause specific and severe dysfunction
to hepatic or central nervous systems. The exposure route for these toxins is oral, from ingestion of recreational water,
and possibly by inhalation.
A range of freshwater microbial agents may cause acute conditions that present with features that resemble illnesses
attributed to contact with cyanobacteria and, conversely, acute illness resulting from exposure to cyanobacteria or
cyanotoxins in recreational waters could be misdiagnosed. Accurately assessing exposure to cyanobacteria in
recreational waters is difficult and unreliable at present, as specific biomarkers are unavailable. However, diagnosis of
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cyanobacteria-related illness should be considered for individuals presenting with acute illness following freshwater
contact if a description is given of a waterbody visibly affected by planktonic mass development.
Introduction
Cyanobacteria are a diverse group of prokaryotes that
occupy a broad range of ecological niches by virtue of
their age, having first appeared some 2.5 billion years ago,
and specialisation. All cyanobacteria are photoau-
totrophic organisms, yet many can grow heterotrophi-
cally, using light for energy and organic compounds as a
carbon source [1]. The cyanobacteria are a remarkably
widespread and successful group, colonising freshwater,
marine and terrestrial ecosystems, including extreme hab-
itats such as Antarctic lakes, salt works and hot springs [2].
Cyanobacteria are common inhabitants of freshwater
lakes and reservoirs throughout the world. Under favour-
able conditions, certain cyanobacteria can dominate the
phytoplankton within a waterbody and form nuisance
blooms.
Cyanobacteria have come to the attention of public health
workers because many freshwater and brackish species
can produce a range of potent toxins. This observation
was first reported over 120 years ago, when sheep, horses,
dogs and pigs were seen to die within hours of drinking
from a lake affected by a bloom of the brackish-water
cyanobacterium  Nodularia spumigena [3]. Since then,
many reports of livestock and wild animal deaths have
appeared in the literature. Such reports have been collated
and discussed by several authors [4-10]. Some reports are
dramatic in terms of the number of animals affected or the
rapid progression of illness and death, with mass deaths
of thousands of animals [11], and large animals succumb-
ing within minutes [12]. Laboratory-based toxicological
investigations have confirmed that freshwater and brack-
ish cyanobacteria produce several categories of toxin that
are (with one exception – the saxitoxins) unique to cyano-
bacteria. The topic of cyanobacterial toxins has been
widely studied, and many excellent texts and reviews are
available, e.g. [8-10,13-26]. Details of the principal cyan-
otoxin groups that are significant from the public health
perspective of acute exposure and outcome are summa-
rised in Table 1. Lipopolysaccharides, which are defining
structural components of the cell walls of Gram-negative
bacteria, are discussed in the accompanying review by
Table 1: Cyanotoxins with public health significance from acute exposures
Toxin or toxin group Classification by 
principal target organ 
systems
Toxin-producing 
genera
LD50(i.p. mouse) References
Microcystins Hepatotoxins Anabaena, Anabaenopsis, 
Aphanocapsa, Arthrospira, 
Hapalosiphon, Microcystis, 
Nostoc, Oscillatoria, 
Planktothrix, Snowella, 
Woronichinia
25->1000 µg/kg [10, 19, 26, 125-128]
Nodularins Hepatotoxins Nodularia 30–60 µg/kg [8, 26, 129]
Anatoxin-a, homoanatoxin-
a
Neurotoxins Anabaena, Aphanizomenon, 
Arthrospira, 
Cylindrospermum, 
Microcystis, Oscillatoria, 
Phormidium, Planktothrix, 
Raphidiopsis
200–375 µg/kg [8, 10, 18, 26, 130-135]
Anatoxin-a(s) Neurotoxin Anabaena 20–40 µg/kg [8, 26, 132]
Saxitoxins Neurotoxins Anabaena, Aphanizomenon, 
Cylindrospermopsis, Lyngbya, 
Planktothrix
10–30 µg/kg [26, 127, 132, 136-140]
Cylindrospermopsin General cytotoxin 
(multiple organ systems 
affected, incl. liver, kidney, 
gastrointestinal tract, heart, 
spleen, thymus, skin)
Anabaena, Aphanizomenon, 
Cylindrospermopsis, 
Raphidiopsis, Umezakia
2.1 mg/kg (24 hours) 200 
µg/kg (5–6 days)
[8, 10, 17, 132, 141-145]
Aplysiatoxin, 
debromoaplysiatoxin
Dermal toxins; probable 
gastro-intestinal 
inflammatory toxin
Lyngbya 107–117 µg/kg [146-152]
Lyngbyatoxin A Possible gastro-intestinal 
inflammatory toxin
Lyngbya 250 µg/kg (?LD100) [153]Environmental Health: A Global Access Science Source 2006, 5:6 http://www.ehjournal.net/content/5/1/6
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Stewart et al [27]. Cyanobacteria are rich sources of bioac-
tive compounds; structurally diverse metabolites with
cytotoxic, tumour-promoting and enzyme-inhibiting
properties are known and presumably many more await
discovery. Some of these metabolites are discussed by
Bickel et al[28] and Forchert et al [29].
A recent report has shown that β-N-methylamino-L-
alanine (BMAA), a neurotoxic non-protein amino acid
associated with an atypical motor neurone disease/Par-
kinsonism/Alzheimer's-like dementia complex, is pro-
duced by a wide variety of cyanobacteria [30]. BMAA is
thought to be capable of binding to endogenous proteins,
in which form it may function as a "slow toxin", and may
be implicated in the aetiology of other long-latency neu-
rodegenerative diseases such as Alzheimer's disease [31].
The public health implications of this cyanobacteria-
related neurotoxicity hypothesis have been further dis-
cussed [32].
Cyanobacterial poisoning of humans has occurred
through known and suspected exposure to cyanotoxin-
contaminated drinking water supplies [33] and reviewed
in: [8-10,34]; confirmed and suspected exposure to con-
taminated dialysate in patients undergoing haemodialysis
[35-39]; and through recreational and occupational con-
tact. This review will concentrate on the latter exposures.
Rationale and search criteria
All references that could be found in the medical and sci-
entific literature, including conference proceedings, which
describe specific incidents involving human illness and
exposure to freshwater cyanobacteria in recreational or in-
field occupational settings are summarised in Additional
File 1. The following citation sources were not examined
for this exercise:
• Reports of cyanobacteria-associated illness from recrea-
tional exposures to marine or estuarine waters.
• Publications written in languages other than English –
with the exception of three papers which we were oppor-
tunistically able to have translated [40-42].
• Newspaper reports – with three exceptions: two reports
describe the first human fatality to be attributed to recrea-
tional contact with cyanobacteria [43,44]. At the time this
review was submitted, these were apparently the only
published references to describe the events surrounding
this tragedy, so were included here because of their impor-
tance. The cyanobacteria research community awaits pub-
lication of a comprehensive case report in the scientific or
medical literature. Another news article supplements a
cursory description in an academic journal (though not a
health-related journal) of cyanobacteria-associated ill-
nesses; both the news report and the scientific publication
appear to describe the same incident, with more detail
provided by the journalist [45,46]. There are undoubtedly
many more publications in the news media that report
suspected cyanobacteria-related human and animal mor-
bidity and mortality: for example Duggan [47] and Ruff
[48] reported on cyanobacteria blooms in Nebraska lakes
that were associated with two dog deaths and more than
40 complaints of acute eye, upper respiratory, gastrointes-
tinal and skin symptoms.
Anecdotal and case reports presented in this review were
identified by the following search strategy:
1. PubMed and Web of Science electronic databases were
searched with the MeSH and textword string "(cyano-
bacter* AND disease outbreaks) OR (cyanobacter* AND
environmental exposure) OR (cyanobacter* AND recrea-
tion*) OR (cyanobacter* AND epidemiology)".
2. Titles and abstracts (when available electronically) were
perused to determine suitability for inclusion.
3. Bibliographies of identified primary papers and related
review articles were reviewed to search for references not
identified by electronic sources.
4. Publications and other sources identified and for-
warded by experts working in this field were included.
The most recent update of the aforementioned electronic
searches, conducted in June 2005, gave 257 citations, of
which 244 were English-language publications and 13
were non-English-language papers. Of these 13 reports,
three (two reviews and one primary article) were identi-
fied from abstracts and/or article titles as worth perusing
for the presence of information about health-related
events associated with recreational exposure to cyanobac-
teria [41,49,50]. One of these papers (the primary article,
in Dutch) and another German review paper we found
with a different search strategy were translated for us, but
there were no previously unreported references in those
papers to specific illness events that were attributed to
contact with cyanobacteria [41,42]. Therefore it does not
appear that there is a significantly large body of unex-
plored literature written in languages other than English
that could contribute to this review. We also corre-
sponded with an author of a publication in Finnish that
we were unable to have translated; this paper discussed
cyanobacteria-related illness in saunas [51]. The findings
of that work were presented at an international confer-
ence, from which an English-language abstract was pub-
lished. The authors reported that 18 subjects (38% of
those questioned) were likely to have experienced cyano-
bacteria-related symptoms [52].Environmental Health: A Global Access Science Source 2006, 5:6 http://www.ehjournal.net/content/5/1/6
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Recreational and in-field occupational exposure to 
cyanobacteria: anecdotal and case reports
Case reports and anecdotal references presented in Addi-
tional File 1 date from 1949 [53], and describe a range of
illnesses associated with recreational exposure to cyano-
bacteria: hay fever-like symptoms, pruritic skin rashes and
gastro-intestinal symptoms are most frequently reported.
Some papers give convincing descriptions of allergic
responses to cyanobacteria [53,54]. Others describe more
serious acute illnesses, with symptoms such as severe
headache, pneumonia, fever, myalgia, vertigo and blister-
ing in the mouth [6,55-57]. The first and so far only
description of a fatality attributed to recreational exposure
to cyanotoxins appeared in news reports recently [43,44].
A U.S. coroner concluded that a teenage boy died as a
result of ingesting anatoxin-a-producing cyanobacteria
from a golf course pond, although there was an unusual
sequence of events preceding the death insofar as the time
period between exposure and death (some 48 hours) does
not tally with the known mechanisms of toxicity of ana-
toxin-a, which initiates pathological signs and death in
laboratory animals within minutes of dosing by either
oral or parenteral routes [58-60]. Animals exposed to ana-
toxin-a-producing cyanobacteria in the field succumb
within minutes to a few hours, depending on the species,
the amount of toxin consumed, and prior food intake
[61]. However, Rogers et al [60] demonstrated delayed
mortality in toad embryos – over 6–13 days post-exposure
– to anatoxin-a. Recent reports in the scientific literature
also add to the uncertainty in the case of the teenager's
death, with suggestions that the preliminary mass spectro-
metric identification of anatoxin-a in the forensic samples
may not be reliable [62-64].
The principal public health concerns regarding recrea-
tional exposures relate to the potential, presumably a
now-realised potential if the aforementioned fatality is
indeed attributable to cyanotoxin poisoning, for exposure
to hazardous levels of cyanotoxins in untreated waters.
Routes of exposure are through direct contact with skin
and mucous membranes, via inhalation, and by inges-
tion, either accidental or deliberate.
Discussion of anecdotal and case reports
Some reports listed in Additional File 1 present scant
information relevant to this topic, with little or no detail
beyond location and the kind of illness reported [65,66].
On the other end of the scale are examples of thorough,
considered case reports, describing relevant medical his-
tory and diagnostic investigations [53,54]. One reason for
the dearth of detail may be that non-specific, mild and
self-limiting illnesses do not merit much discussion, how-
ever, some references to more serious illnesses leave a
great deal unanswered, for example the 12 year-old boy
who reportedly lapsed into unconsciousness for a six-
hour period, and developed pneumonia, myalgia and
arthralgia [67]. It would have been very interesting to
know whether or not this boy had any predisposing med-
ical conditions (e.g. diabetes, epilepsy) that might have
explained the loss of consciousness, whether any medical
attention was sought, and, if so, the details of his disease
progression.
The observation that repeated water contact in a particular
lake preceded a skin eruption on a six year-old girl, while
other bathers appeared unaffected, helped support a diag-
nosis of hypersensitivity in that case [54]. One of the few
reports of mass effects, with 20–30 children suffering con-
junctival and upper respiratory symptoms during a school
aquatic event, is tempered by the observation that that
number represented about 25% of those exposed [68]. So
hypersensitivity reactions affecting a sub-set of allergy-
prone children may also be an explanation for the latter
outbreak, although this speculation – in the absence of
any other reported investigations – is solely based on that
estimate of 25% of those exposed experiencing symp-
toms.
Those reports that have indicated symptom onset time
suggest that responses can be rapid, with some urticarial
and hay fever-like symptoms commencing while subjects
are still in the water [53,68]. While a disparate range of
signs and symptoms are listed, several reports describe a
collective group of symptoms resembling immediate or
Type-I hypersensitivity reactions. Immediate hypersensi-
tivity reactions are commonly associated with atopy,
which is the familial tendency to react to naturally occur-
ring antigens, mostly proteins, through an IgE-mediated
process. Atopy frequently manifests as a spectrum of dis-
eases, e.g. seasonal rhinitis, conjunctivitis, asthma and
urticaria. Different atopic illnesses often affect the same
individual. A fundamental feature of Type-I hypersensitiv-
ity reactions is the rapid onset of symptoms – normally
seconds to minutes – following exposure to antigens [69-
73].
Some serious though apparently self-limiting gastro-intes-
tinal illnesses have been reported after contact with
cyanobacteria in recreational waters, presumably through
ingestion of affected water. Dillenberg & Dehnel [55]
describe how an adult male inadvertently swallowed lake
water affected by a bloom of Microcystis sp. and Anabaena
circinalis. After some three hours he developed cramping
abdominal pain and nausea, which progressed to painful
diarrhoea followed by a fever of 38.9°C, severe headache,
lassitude, myalgia and arthralgia. Such illnesses are worry-
ing, considering the two boys that were sickened – one of
whom subsequently died – after possible exposure to
cyanobacteria in a golf course pond suffered acute and
severe gastro-intestinal illnesses [43].Environmental Health: A Global Access Science Source 2006, 5:6 http://www.ehjournal.net/content/5/1/6
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Occupational exposures were included in this review,
although some caution should be exercised when com-
paring occupational and recreational exposures. Waters
that are obviously discoloured or visibly affected by
cyanobacteria scums may be of interest to aquatic field
workers who are keen and/or obliged to collect samples.
The two incidents involving British soldiers and sea cadets
conducting canoe capsizing activities, presumably under
orders from their supervising officers, occurred in waters
that were reportedly subject to a "heavy bloom of Micro-
cystis spp" [74] and a "scum of Oscillatoria..." [23]. Waters
that are obviously suffering a loss of visual amenity may
be shunned by many recreational users, although avoid-
ance behaviour in such circumstances cannot be taken for
granted [75].
The other reports that are of particular interest are those
grouped under "cold & flu-like symptoms". Several publi-
cations describe individuals presenting with a flu-like ill-
ness, with signs and symptoms including fever, headache,
lassitude, arthralgia, myalgia, sore throat, cough, diar-
rhoea and vomiting. A proposed explanation for this con-
stellation of symptoms is that of a coordinated, cytokine-
mediated innate immune response. Fever and malaise are
events that are directed by endogenous mediators; for fur-
ther discussion see [75]. This spectrum of signs and symp-
toms also mimics those reported in volunteer studies of
intravenous Gram-negative bacterial LPS injection [76-
79]. Mammalian responses to LPS are mediated by
inflammatory cytokines (see accompanying review by
Stewart et al [27]). The early signs and symptoms of influ-
enza infection (fever, myalgia, fatigue, drowsiness, rhinor-
rhoea, sore throat, headache) are mediated by pro-
inflammatory cytokines, particularly IFN-α and IL-6 [80-
83]. Flu-like reactions to immunostimulant drugs are
sometimes referred to as "acute cytokine syndromes" [84],
and the flu-like syndrome of fever, rigors, tachycardia,
malaise, headache, arthralgia and myalgia that accompa-
nies interferon pharmacotherapy is thought to be due to
the release of eicosanoids, IL-1 and TNF-α [85].
Epidemiology of recreational exposure to cyanobacteria
Six epidemiological studies of recreational exposure to
cyanobacteria were identified with the search strategy dis-
cussed previously: three analytical cross-sectional studies
from the U.K. using similar survey instruments [86-88], a
small case-control study from Australia [89], and two
larger prospective cohort studies, also from Australia
[90,91]. Table 2 lists the pertinent findings of these stud-
ies, which are discussed in detail below.
The three cross-sectional studies were conducted by
Philipp and co-workers [86-88]. Questionnaires were dis-
tributed to recreational users of six inland waterbodies,
five of which experienced cyanobacteria blooms during
1990. The questionnaires elicited information on expo-
sure to study waters and the presence of specific symp-
toms in a defined period prior to receiving the form. This
period ranged from 14 days [87] to four weeks [88]. One
questionnaire asked about exposure to the study water on
a weekend when a bloom occurred some 21/2 weeks pre-
viously [86]. Recreational interest groups were used to tar-
Table 2: Summary of epidemiological studies investigating recreational exposure to cyanobacteria
Country; year study 
conducted; study 
author/s; reference
Study design Main outcomes 
reported
Study size (n) Odds ratio (95% 
confidence interval)
UK, 1990 Philipp [86] Cross-sectional No statistically significant 
findings
246
UK, 1990 Philipp & Bates 
[87]
Cross-sectional No statistically significant 
findings
363
UK, 1990 Philipp et al [88] Cross-sectional No statistically significant 
findings
246
Australia, 1992 El Saadi et 
al [89]
Case-control No statistically significant 
findings
Approx. 48 (subjects 
reporting recreational 
exposure)
Australia, 1995 Pilotto et al 
[90]
Prospective cohort Increased symptoms at 7 
days following exposure to 
more than 5,000 
cyanobacterial cells/mL for 
>1 hour vs non-bathers
852 (total)
338 (no prior exposure or 
symptoms)
1.3 (0.7–2.6)
3.4 (1.1–10.8)
Australia & USA, 1999–
2002 Stewart et al [91]
Prospective cohort Increased reporting of mild 
respiratory symptoms and 
any symptom at 3 days 
following exposure to 
cyanobacteria cell surface 
area >12 mm2/mL vs <2.4 
mm2/mL
1,331 (total)
1,137 (no prior symptoms)
1,149 (no prior respiratory 
symptoms)
1.7 (1.0–2.9) (any 
symptom)
2.1 (1.1–4.0) (respiratory 
symptoms)Environmental Health: A Global Access Science Source 2006, 5:6 http://www.ehjournal.net/content/5/1/6
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get likely users of the waterbodies; questionnaires were
mailed to members of sailing and angling clubs. Site
authorities distributed questionnaires at one study lake
[88]. The results of these three studies were similar: mostly
minor morbidity was reported, with similar disease pat-
terns across sites.
The theoretical advantages of this study type are that it is
reasonably cost-effective, and in this context – recrea-
tional exposure to cyanobacteria – it can be conducted
opportunistically to take advantage of any sudden-onset
cyanobacteria blooms. Disadvantages relate to the diffi-
culty in establishing that exposure occurred before the
outcome [92,93]. The studies conducted by Philipp and
his team [86-88] were examples of analytical cross-sec-
tional studies, in that unexposed individuals served as
controls for statistical comparison of illness reporting.
A case-control study of illness rates was conducted after an
extensive  Anabaena circinalis-dominant bloom along
South Australia's Murray River in the summer of 1991–
1992 [89]. Patients presenting with gastro-intestinal (G-I)
or dermatological complaints comprised the case group;
the patient presenting after each case was identified served
as the control group. Exposure was determined by identi-
fying each subject's principal source of water for drinking,
domestic use (bathing, dishwashing) and recreation dur-
ing the week prior to consultation. Recreational exposure
was categorised as no contact, direct exposure to river
water, or other exposure, e.g. farm dams or treated water
in swimming pools. The study found a significantly
increased risk of G-I symptoms for those drinking chlorin-
ated river water, and an increased risk of G-I and cutane-
ous symptoms in those using untreated river water for
domestic purposes. There was a statistically non-signifi-
cant increase in the relative odds of developing G-I or skin
symptoms amongst those with recreational exposure to
river water, but that risk was lower than for those exposed
to other sources of recreational water (tank, farm dam or
another location). The number of subjects was small for
the recreational exposure component of the study, with
only some 50 subjects (16% of the study group) reporting
any recreational exposure during the study period [89].
The advantages of a case-control design for investigating
recreational exposure to cyanobacteria are that studies can
be conducted opportunistically in response to the devel-
opment of cyanobacteria blooms, and they are very useful
for investigating infrequent outcomes. The study of El
Saadi et al [89] has another advantage over other epidemi-
ological studies into recreational exposure to cyanobacte-
ria in that medical practitioners ascertained outcome data,
as opposed to self-reporting of symptoms. General disad-
vantages of the case-control design principally relate to
the problem of recall bias, where individuals with the dis-
ease of interest tend to overestimate relevant past expo-
sures [92,93]. Because the outcome has already occurred
when exposure is measured, people with disease may sys-
tematically overestimate (or underestimate) their expo-
sure compared to disease-free controls, leading to falsely
elevated (or reduced) measures of risk associated with
exposure. Another major issue with case-control studies is
the difficulty of identifying an appropriate control group
– i.e. people who would have been identified as cases if
they had the disease of interest.
Recall bias may not be so much of a problem for investi-
gating acute illnesses following recreational exposure to
cyanobacteria, where a fairly short time lag between expo-
sure and symptom onset can be anticipated, especially if
recreational exposure is determined by a yes/no response.
The main problem with a case-control study in this con-
text will be in actually identifying cases. A case-control
design would not be suitable for investigating outcomes
from exposure to a cyanobacteria bloom in a lake adjacent
to a city, as most recreational users who do develop symp-
toms would presumably seek medical attention after they
return home, i.e. from one of a large number of medical
practitioners. El Saadi et al [89] alluded to the difficulty of
gaining the cooperation of medical practitioners, as they
approached practices in 11 towns along the Murray River,
yet those in three towns presumably refused to participate
in their study. The diffuse spread of cases from point
sources of exposure (a cyanobacteria-affected waterbody)
across a large town or city would make a case-control
study practically unworkable. A case-control study would
also be unsuitable for recruiting subjects who did not seek
medical attention for symptoms occurring after exposure.
However, a well-designed case-control study would be
valuable if geographical location is a primary considera-
tion. This would require enlisting the cooperation of med-
ical practitioners in small townships near to
cyanobacteria-affected recreational waters that are suffi-
ciently remote from larger urban centres to allow recruit-
ment of local residents and tourists who will camp
nearby.
The studies by Pilotto et al [90] and Stewart et al [91] were
prospective cohort studies. Pilotto et al [90] recruited
individuals at five recreational waterbodies in three Aus-
tralian states. Cyanobacteria blooms were anticipated at
these sites, based on occurrences in previous years. Indi-
viduals were approached and invited to participate in the
study. Participants completed a face-to-face interview to
determine health status and recreational water activities;
two telephone follow-up interviews were conducted at
two and seven days following the day of recruitment into
the study. Individuals who did not have water contact on
the recruitment day served as the control group. No signif-
icant differences in symptom occurrence were reported atEnvironmental Health: A Global Access Science Source 2006, 5:6 http://www.ehjournal.net/content/5/1/6
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the 2nd day follow-up, but the authors concluded there
was a significant increase in symptoms at 7 days, after
excluding subjects with symptoms or previous recent rec-
reational water exposure. The cohort size from which
these significant results were drawn was rather small, with
93 exposed subjects, and 43 unexposed controls. Pilotto
et al [90] interpreted the increased symptom reporting at
7 days but not 2 days following exposure as possibly due
to delayed allergic responses, although so-called "late
phase" allergic and asthmatic responses tend to occur
some 4–24 hours after allergen exposure [69,94,95].
Stewart et al [91] also conducted a cohort study of recrea-
tional exposure to cyanobacteria. 1,331 subjects were
recruited from 19 recreational waterbodies in eastern Aus-
tralia and central and northeast Florida; subjects com-
pleted a self-administered questionnaire to determine
recreational activity, recent illness and history of any rele-
vant chronic diseases such as asthma, hay fever and
eczema. A single follow-up telephone interview was con-
ducted after three days post-exposure. Reference subjects
were recruited at recreational waters unaffected by cyano-
bacteria; exposure categories (low, intermediate, high)
were allocated to study subjects on the basis of cyanobac-
teria levels measured in study water samples collected on
the day they were recruited into the study. Statistically sig-
nificant increased reporting of respiratory symptoms and
a pooled "any symptom" category occurred amongst sub-
jects exposed to high levels of cyanobacteria, although
symptoms were predominantly rated as mild by study
subjects. A similar but non-significant relationship was
also seen for reporting of skin, ear and fever symptom
groups.
The studies of Pilotto et al [90] and Stewart et al [91] are
both examples of a prospective cohort design, where study
subjects have their exposure status determined, and are
then followed forward in time to observe the develop-
ment of disease. For these investigations into recreational
exposure to cyanobacteria, exposure status was deter-
mined by collecting water samples on the day subjects
were recruited into the study; cyanobacteria were identi-
fied and enumerated and the resultant cell counts or bio-
mass estimates formed the basis of exposure at any given
site on a particular day. One of the problems with this
approach is that cyanobacteria blooms are dynamic and
can change rapidly. Unless the presence of significant
cyanobacterial biomass can be predicted with some
degree of certainty, a prospective cohort design can result
in wasted effort if the water samples reveal lower than
anticipated levels of cyanobacteria. This problem
undoubtedly occurred in some instances during the study
conducted by Stewart et al [91]. One possible approach to
dealing with this would be to conduct a historical cohort
study, where a cohort of subjects is identified after some
have experienced the outcome of interest and relevant
exposure information is obtained from historical records
(i.e. as in a prospective cohort study the exposure infor-
mation was recorded before any outcomes occurred).
Whether a cohort study is conducted prospectively or ret-
rospectively, the basic study design is identical – exposed
and unexposed groups are compared with respect to dis-
ease outcome [93]. General advantages of a cohort design
are the ability to determine disease onset (the exposure
precedes the disease), and the study of exposures in natu-
ral settings [92]. General disadvantages relate to con-
founding, which refers to differences in the distribution of
risk factors other than the exposure of interest between
exposed and unexposed groups. Cohort studies can be
expensive and resource intensive [92].
Further discussion of some common epidemiological
study designs that may be useful for investigating the topic
of recreational exposure to aquatic cyanobacteria, with
particular emphasis on the relative advantages and disad-
vantages of experimental epidemiology (randomised tri-
als) is presented by Stewart [75].
Cyanobacteria and water-related disease: some 
complicating factors
Other explanations for disease need to be considered by
both clinicians and epidemiologists in their respective
endeavours. Epidemiological studies usually aim to iden-
tify and adjust for confounding variables such as smoking
and age of study participants. The following sections will
discuss some freshwater-related risk factors, mostly micro-
bial, that may confound epidemiological studies and
complicate clinical diagnoses of cyanobacteria-related ill-
ness linked to recreational exposures. The final section of
this review will discuss the possibility of misdiagnosis
from the opposite direction: a water-borne disease out-
break in Finland that was subject to epidemiological scru-
tiny, but cyanobacterial exotoxin contamination of
reticulated supplies was apparently not considered at the
time.
Freshwater-related dermatoses
• Avian cercariae: avian cercariae are schistosome larvae
for which humans are an accidental host. Pruritus and
macules are the initial signs and symptoms; sometimes a
diffuse erythema and urticaria can develop and last for
several hours [96-99]. Fever, nausea and vomiting can
also accompany severely affected cases [97,100]. The clin-
ical presentation of cercarial dermatitis can be difficult to
delineate from the picture of cyanobacterial dermatitis.
• Gram-negative bacteria: Aeromonas hydrophila and Chro-
mobacterium violaceum are abundant in freshwater habi-
tats. Both usually cause infection through a pre-existingEnvironmental Health: A Global Access Science Source 2006, 5:6 http://www.ehjournal.net/content/5/1/6
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skin wound, though the clinical presentations in each case
do not match of any of the reports listed in Additional File
1. A. hydrophila causes cellulitis and a purulent discharge;
aspiration of water can cause pneumonia and septicae-
mia. C. violaceum infections present with various cutane-
ous signs that are secondary to systemic disease, including
sepsis [101]. Vibrio vulnificus has reportedly caused soft tis-
sue infection after contact in brackish inland waters,
though most cases are associated with estuarine contact
[102]. Pseudomonas aeruginosa is widely-distributed in nat-
ural and artificial aquatic environments. Cutaneous infec-
tion presents as an erythematous or urticarial rash some
18–24 hours after water contact and progresses to a follic-
ular dermatitis. Fever and pruritus are uncommon. Most
reports of pseudomonal dermatitis are related to spa pool
or hot-tub exposures [102,103]. P. aeruginosa in recrea-
tional waters is a common cause of otitis externa, present-
ing as a purulent discharge [102]. Diagnostic criteria
include culturing the organism from skin or ear swabs; the
incubation period would also help to distinguish P. aeru-
ginosa infection from cyanobacteria-related dermatoses.
• Non-allergic urticaria: physical stimuli such as heat,
cold and exercise can induce itching and hives in suscep-
tible individuals [99,104].
Gastro-intestinal illness
• Shigellosis: Shigella outbreaks are the most commonly
reported cause of disease associated with untreated inland
recreational water in the USA, with 16 events affecting
almost 1,300 people between 1985 and 1994 [102]. The
incubation period is typically 2–3 days, with an upper
limit of about 7 days. Illness severity is strain-dependent,
with most S. sonnei infections being mild and self-limit-
ing, and S. dysenteriae type 1 associated with severe diar-
rhoea which may progress to a life-threatening illness
[102].
• Escherichia coli: E. coli are markers of faecal pollution in
recreational waters. Disease outbreaks traced to entero-
haemorrhagic E. coli 0157 have been reported from recre-
ational water exposures [102,105].
•  Norwalk-like viruses: Various transmission routes,
including recreational water outbreaks have been docu-
mented [105].
Other microbial pathogens
• Naegleria fowleri: N. fowleri is a free-living thermotoler-
ant amoeba found in warm or thermally polluted waters.
It is the causative organism of primary amoebic menin-
goencephalitis, a fulminating, typically fatal illness. The
entry route is via the nasal mucosa; fit, immunocompe-
tent children and young adults with a recent history of
freshwater recreational activity are those most commonly
affected. The causative organism and diagnosis are usually
confirmed at autopsy. Several reviews are available, e.g.
[106-113].
• Viruses: Pharyngo-conjunctival fever outbreaks associ-
ated with non-enteric adenoviruses in recreational waters
have been reported [105].
• Legionella: Legionella infections have been associated
with recreational water contact [105].
Possible under-diagnosis of cyanobacteria-related illness
The examples given above highlight some of the differen-
tial diagnoses that need to be worked through when con-
sidering possible cases of cyanobacteria-related illness
from recreational exposures. Competent history-taking
and diagnostic microbiology support will correctly diag-
nose many such cases. Competent history-taking and clin-
ical diagnostic support also operated in several of the case
reports listed in Additional File 1, with the early dermato-
logical testing and microscopic examination of stool and
vomitus samples lending strong support to the suspicion
of cyanobacteria-related morbidity.
Misdiagnosis of cyanobacteria-related disease may occur
in both directions. In 1978, nearly half the population of
an industrial town in Finland were affected by a flu-like
illness, with symptoms of fever, fatigue, cough, dyspnoea
and myalgia. Symptoms occurred some 3–6 hours after
taking a bath, shower or sauna and persisted for 8–16
hours. The outbreak lasted for some four months. This
epidemic was investigated on several fronts, and provoca-
tion testing demonstrated an obvious link to the reticu-
lated water supply. Tap water was cultured in a range of
organic media for fungal and bacterial pathogens. No
definitive pathogen was identified to explain the epi-
demic, yet in three published reports the authors describe
how the shallow lake that was the town water source had
taken on a distinct opaque blue-green appearance, had a
musty smell, and the sand filtration system was covered
by a mat of cyanobacteria. This change occurred in the
same month (August, i.e. late summer) that the epidemic
began. Analysis of crude lake water in the third month
after the onset of the epidemic showed high coliform
counts, Aspergillus fumigatus and unspecified blue-green
algae. Investigations centred on identifying antibodies to
mesophilic actinomycetes, which the authors [114] note
were not pathogenic, whereas aquatic cyanobacteria were
known at the time to be toxic. The health workers investi-
gating the outbreak apparently did not consider the possi-
bility of a cyanobacterial exotoxin breakthrough into the
reticulated supply [114-118]. The epidemiological report
of Aro et al [115] came closest to suggesting that cyano-
bacteria may have been involved, suggesting that
"towards the end of summer....the microorganisms in theEnvironmental Health: A Global Access Science Source 2006, 5:6 http://www.ehjournal.net/content/5/1/6
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lake multiply rapidly and produce some toxic substance
or allergen", and reported that cyanobacterial endotoxin
concentration in lake and tap water was high. This inci-
dent appears to have been retrospectively attributed to the
presence of cyanobacterial endotoxins (i.e. LPS) in the
reticulated supply [119]. A similar outbreak occurred
almost three years earlier in a Swedish town, though with
a much smaller proportion of cases identified. Cyanobac-
teria were known to affect the town's raw water supply,
and the investigators did consider the possibility that cya-
notoxins may have been responsible for the outbreak
[120], though the analytical technique used by investiga-
tors at the time – gas chromatography – would have failed
to detect the presence of cyanobacterial exotoxins in the
post-treatment water supply. While no conclusions can be
made about events that occurred over 25 years ago, from
the descriptions of the outbreaks and the raw water sup-
plies, most cyanobacterial toxicologists would rate cyano-
toxin exposure with a high index of suspicion.
A similar outbreak occurred more recently in Homa Bay,
Kenya, in 1998. Apparently associated with a mass devel-
opment of cyanobacteria in Lake Victoria, an epidemic of
fever, malaise, dizziness and upper respiratory symptoms
was related to hot water bathing. Symptoms lasted 12–24
hours, and returned when a shower or bath was taken
again. This outbreak was reported in a conference abstract;
the authors suggested cyanobacterial endotoxins were
responsible, though it is not stated whether any investiga-
tion of cyanobacterial exotoxins was conducted [121].
Conclusion
The true incidence of acute cyanobacteria-associated ill-
ness from recreational exposure is unknown, as many out-
comes are likely to be mild and self-limiting, so medical
attention is not sought. With a long-standing knowledge
gap amongst primary healthcare providers, non-specific
signs and symptoms caused by cyanobacterial products
are likely to be under-diagnosed [8]. Codd [122] stated:
"Evidence linking human illnesses with cyanobacterial
cells and toxins is open to criticism because of shortfalls
in early detailed case definitions, because diagnoses were
made by exclusion, and because identification and quan-
tification of cyanobacterial toxins in health incidents
have, until recently, been lacking."
The collation of anecdotal and case reports of illness asso-
ciated with recreational exposure to cyanobacteria in
Additional File 1 will hopefully highlight some of the
knowledge gaps. Particular attention should be given to
determining the onset and duration of individual symp-
toms in future case reporting, as well as detailing the pres-
ence or absence of any predisposing medical conditions.
A recent initiative of UNESCO's International Hydrology
Programme has been to establish CyanoNet, which is a
"Global network for the hazard management of cyano-
bacterial blooms and toxins in water resources". The
CyanoNet website will carry information on various asso-
ciated topics, including "Reported incidents of adverse
health effects including case studies" and "Surveys and
epidemiological studies investigating associations
between cyanobacterial populations, cyanotoxins and
health" [123].
The most important advances in understanding the health
impacts of cyanobacteria have come from the discipline of
toxicology. The major toxins have been extensively stud-
ied and characterised, and while there is still much to be
discovered in the field of cyanobacterial toxicology, signif-
icant advances in the future will be made at the interface
of toxicology and epidemiology. Molecular epidemiology
techniques using yet-to-be discovered biomarkers of
exposure, susceptibility and outcome will refine knowl-
edge of the risks associated with various acute and chronic
exposures to cyanotoxins. The collaborative skills that epi-
demiologists and toxicologists can bring to this endeav-
our were viewed with a mildly jaundiced eye by Paddle
[124], whose chapter on epidemiology for toxicologists is
an excellent general primer:
"The total evidence about the risk to humans...will consist
of the toxicologist's precise, experimental data about the
wrong species at the wrong exposure, and the epidemiol-
ogist's imprecise, observational data about the right spe-
cies at the right exposure."
In conclusion, anecdotal and case reports of variable reli-
ability have suggested a range of symptoms are associated
with exposure to cyanobacteria in recreational or occupa-
tional settings. Some reports of cutaneous reactions are
strongly suggestive of allergic reactions, and symptoms
such as rhinitis, conjunctivitis, asthma and urticaria also
hint at immediate hypersensitivity responses. Flu-like ill-
nesses involving a constellation of symptoms including
fever, malaise, myalgia, arthralgia, severe headache, cough
and sore throat are, in our opinion, explained by a cascade
action of pro-inflammatory cytokines. If correct, this
implies that some cyanobacterial products possess ligands
that induce innate immune responses, and such responses
may need to be considered in terms of their potential to
direct pathological changes in the liver and other organ
systems.
The epidemiology of recreational exposure to cyanobacte-
ria is incomplete at present. All common epidemiological
approaches have their own inherent advantages and dis-
advantages; identification of biomarkers for exposure,
susceptibility and outcome in the future should lead to aEnvironmental Health: A Global Access Science Source 2006, 5:6 http://www.ehjournal.net/content/5/1/6
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significantly improved perception of the risks of bathing
in cyanobacteria-affected waters.
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